{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:59:19Z","timestamp":1790135959110,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["173414"],"award-info":[{"award-number":["173414"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Diabetic cardiomyopathy (DCM) is a major complication of diabetes and a risk factor for cardiovascular disease. Endothelial dysfunction is central to DCM, and endothelial-to-mesenchymal transition (EndMT) is a key form of endothelial dysfunction in diabetes. EndMT in DCM has been well-studied in model systems and has been found to be epigenetically regulated by non-coding RNAs (ncRNAs). However, EndMT in DCM and its associated epigenetic changes need further characterization in human patients. It is also not known if ncRNAs are affected by changes in DNA methylation in DCM. This study aims to confirm in human hearts, the findings from animal and cell studies, and potentially provide novel insight into interactions between DNA methylation and ncRNAs in EndMT in DCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and results<\/jats:title>\n                <jats:p>Heart tissues were collected from autopsy patients, fixed in formalin, and embedded in paraffin. Thin sections from paraffin-embedded tissues were used for histology and immunofluorescence analyses, where we confirmed that diabetic patients showed increased cardiac fibrosis that EndMT had occurred. Tissue curls from the paraffin-embedded tissues were used for RT-qPCR and methylation analyses. RT-qPCR quantitatively showed that EndMT occurs in the hearts of diabetics, and that EndMT in human hearts corresponded to changes in key ncRNAs. Methylation analysis showed that some of the EndMT-related ncRNAs were regulated by DNA promoter methylation, while others may be regulated through different epigenetic mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We show that EndMT is a relevant pathological process in human hearts during DCM, and that its occurrence coincides with changes in relevant ncRNAs. We further find that interplay between DNA methylation and certain ncRNAs involved in the regulation of EndMT may contribute to the observed changes in ncRNA expression. These findings reinforce the role of EndMT in patients afflicted with DCM and underscore the complexities and importance of the interactions between different facets of epigenetic regulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-02039-4","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:01:58Z","timestamp":1699038118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation"],"prefix":"10.1186","volume":"22","author":[{"given":"Eric","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"issue":"4","key":"2039_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011295","volume":"8","author":"S Raghavan","year":"2019","unstructured":"Raghavan S, Vassy JL, Ho Y, Song RJ, Gagnon DR, Cho K, et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc. 2019;8(4): e011295.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2039_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia\u2014and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21\u20138.","journal-title":"Diabetologia"},{"issue":"10","key":"2039_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4239\/wjd.v10.i10.490","volume":"10","author":"L Athithan","year":"2019","unstructured":"Athithan L, Gulsin GS, McCann GP, Levelt E. Diabetic cardiomyopathy: pathophysiology, theories and evidence to date. World J Diabetes. 2019;10(10):490\u2013510.","journal-title":"World J Diabetes"},{"key":"2039_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154910","volume":"125","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, et al. Heart failure in diabetes. Metabolism. 2021;125: 154910.","journal-title":"Metabolism"},{"issue":"6","key":"2039_CR5","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"1","key":"2039_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11154-012-9232-6","volume":"14","author":"EJ Barrett","year":"2013","unstructured":"Barrett EJ, Liu Z. The endothelial cell: an \u201cearly responder\u201d in the development of insulin resistance. Rev Endocr Metab Disord. 2013;14(1):21\u20137.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2039_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D\u2019Antoni ML, Debuque R, et al. Revisiting cardiac cellular composition. Circ Res. 2016;118(3):400\u20139.","journal-title":"Circ Res"},{"issue":"3","key":"2039_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.2337\/db15-1033","volume":"65","author":"B Feng","year":"2016","unstructured":"Feng B, Cao Y, Chen S, Chu X, Chu Y, Chakrabarti S. miR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy. Diabetes. 2016;65(3):768\u201379.","journal-title":"Diabetes"},{"issue":"10","key":"2039_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276076","volume":"17","author":"B Feng","year":"2022","unstructured":"Feng B, Liu J, Wang E, Su Z, Chakrabarti S. Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1. PLoS ONE. 2022;17(10): e0276076.","journal-title":"PLoS ONE"},{"key":"2039_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1050540","author":"E Wang","year":"2023","unstructured":"Wang E, Wang H, Chakrabarti S. Endothelial-to-mesenchymal transition: an underappreciated mediator of diabetic complications. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1050540.","journal-title":"Front Endocrinol"},{"issue":"8","key":"2039_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","volume":"124","author":"J Bischoff","year":"2019","unstructured":"Bischoff J. Endothelial-to-mesenchymal transition. Circ Res. 2019;124(8):1163\u20135.","journal-title":"Circ Res"},{"issue":"2","key":"2039_CR12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez S, Jimenez SA. Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev. 2019;99(2):1281\u2013324.","journal-title":"Physiol Rev"},{"issue":"8","key":"2039_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"14","author":"N Clere","year":"2020","unstructured":"Clere N, Renault S, Corre I. Endothelial-to-mesenchymal transition in cancer. Front Cell Dev Biol. 2020;14(8):747.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2039_CR14","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/ATVBAHA.118.311276","volume":"38","author":"MS Hulshoff","year":"2018","unstructured":"Hulshoff MS, Xu X, Krenning G, Zeisberg EM. Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease. Arterioscler Thromb Vasc Biol. 2018;38(9):1986\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2039_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fimmu.2018.00294","volume":"20","author":"JG Cho","year":"2018","unstructured":"Cho JG, Lee A, Chang W, Lee MS, Kim J. Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 2018;20(9):294.","journal-title":"Front Immunol"},{"key":"2039_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.683594","author":"R Giordo","year":"2021","unstructured":"Giordo R, Ahmed YMA, Allam H, Abusnana S, Pappalardo L, Nasrallah GK, et al. EndMT regulation by small RNAs in diabetes-associated fibrotic conditions: potential link with oxidative stress. Front Cell Dev. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.683594.","journal-title":"Front Cell Dev"},{"issue":"2","key":"2039_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3132\/dvdr.2007.025","volume":"4","author":"MM Hartge","year":"2007","unstructured":"Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res. 2007;4(2):84\u20138.","journal-title":"Diab Vasc Dis Res"},{"issue":"11","key":"2039_CR18","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1167\/iovs.14-15167","volume":"55","author":"Y Cao","year":"2014","unstructured":"Cao Y, Feng B, Chen S, Chu Y, Chakrabarti S. Mechanisms of endothelial to mesenchymal transition in the retina in diabetes. Invest Ophthalmol Vis Sci. 2014;55(11):7321.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"2039_CR19","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","volume":"121","author":"B Widyantoro","year":"2010","unstructured":"Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation. 2010;121(22):2407\u201318.","journal-title":"Circulation"},{"key":"2039_CR20","first-page":"246","volume":"5","author":"A Moosavi","year":"2016","unstructured":"Moosavi A, Motevalizadeh AA. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016;5:246\u201358.","journal-title":"Iran Biomed J"},{"key":"2039_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02483","author":"D Fr\u00edas-Lasserre","year":"2017","unstructured":"Fr\u00edas-Lasserre D, Villagra CA. The Importance of ncRNAs as epigenetic mechanisms in phenotypic variation and organic evolution. Front Microbiol. 2017. https:\/\/doi.org\/10.3389\/fmicb.2017.02483.","journal-title":"Front Microbiol"},{"issue":"1","key":"2039_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacol. 2013;38(1):23\u201338.","journal-title":"Neuropsychopharmacol"},{"issue":"3","key":"2039_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/cvr\/cvr097","volume":"90","author":"MU Kaikkonen","year":"2011","unstructured":"Kaikkonen MU, Lam MTY, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res. 2011;90(3):430\u201340.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2039_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2039_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1741-7007-11-59","volume":"11","author":"AE Kornienko","year":"2013","unstructured":"Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013;11(1):59.","journal-title":"BMC Biol"},{"issue":"9","key":"2039_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"3","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;3(9):402.","journal-title":"Front Endocrinol"},{"issue":"7","key":"2039_CR27","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1261\/rna.1541209","volume":"15","author":"K Miyoshi","year":"2009","unstructured":"Miyoshi K, Okada TN, Siomi H, Siomi MC. Characterization of the miRNA-RISC loading complex and miRNA-RISC formed in the drosophila miRNA pathway. RNA. 2009;15(7):1282\u201391.","journal-title":"RNA"},{"issue":"3","key":"2039_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"},{"issue":"4","key":"2039_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2478\/s11658-014-0212-6","volume":"19","author":"Z Wu","year":"2014","unstructured":"Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q, et al. Regulation of lncRNA expression. Cell Mol Biol Lett. 2014;19(4):561\u201375.","journal-title":"Cell Mol Biol Lett"},{"issue":"268","key":"2039_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2018.04.082","volume":"1","author":"S Costantino","year":"2018","unstructured":"Costantino S, Paneni F, Mitchell K, Mohammed SA, Hussain S, Gkolfos C, et al. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. Int J Cardiol. 2018;1(268):179\u201386.","journal-title":"Int J Cardiol"},{"issue":"191","key":"2039_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijcard.2015.04.245","volume":"15","author":"R Guo","year":"2015","unstructured":"Guo R, Liu W, Liu B, Zhang B, Li W, Xu Y. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: an insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 2015;15(191):36\u201345.","journal-title":"Int J Cardiol"},{"key":"2039_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114716","volume":"192","author":"L Chen","year":"2021","unstructured":"Chen L, Shang C, Wang B, Wang G, Jin Z, Yao F, et al. HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosis. Biochem Pharmacol. 2021;192: 114716.","journal-title":"Biochem Pharmacol"},{"key":"2039_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131178","author":"L Lecce","year":"2021","unstructured":"Lecce L, Xu Y, V\u2019Gangula B, Chandel N, Pothula V, Caudrillier A, et al. Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI131178.","journal-title":"J Clin Invest"},{"key":"2039_CR34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00089.2020","author":"Y He","year":"2021","unstructured":"He Y, Dan Y, Gao X, Huang L, Lv H, Chen J. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K\/Akt\/mTOR signaling pathway. Am J Physiol Endocrinol Metab. 2021. https:\/\/doi.org\/10.1152\/ajpendo.00089.2020.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2039_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13098-022-00966-y","volume":"15","author":"MS Hulshoff","year":"2023","unstructured":"Hulshoff MS, Schellinger IN, Xu X, Fledderus J, Rath SK, Wong FC, et al. miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus. Diabetol Metab Syndr. 2023;15(1):11.","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"2039_CR36","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2337\/db10-1557","volume":"60","author":"K McArthur","year":"2011","unstructured":"McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes. 2011;60(4):1314\u201323.","journal-title":"Diabetes"},{"issue":"11","key":"2039_CR37","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.2337\/db11-0478","volume":"60","author":"B Feng","year":"2011","unstructured":"Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, et al. miR-146a\u2013mediated extracellular matrix protein production in chronic diabetes complications. Diabetes. 2011;60(11):2975\u201384.","journal-title":"Diabetes"},{"issue":"7","key":"2039_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.64.7.13","volume":"64","author":"E Wang","year":"2023","unstructured":"Wang E, Feng B, Chakrabarti S. MicroRNA 9 is a regulator of endothelial to mesenchymal transition in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2023;64(7):13.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2039_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-4598-9-16","volume":"26","author":"HY Wan","year":"2010","unstructured":"Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-\u03baB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 2010;26(9):16.","journal-title":"Mol Cancer"},{"issue":"10","key":"2039_CR40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.15252\/embr.201540750","volume":"16","author":"M Fierro-Fern\u00e1ndez","year":"2015","unstructured":"Fierro-Fern\u00e1ndez M, Busnadiego \u00d3, Sandoval P, Espinosa-D\u00edez C, Blanco-Ruiz E, Rodr\u00edguez M, et al. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX 4 and TGFBR 2. EMBO Rep. 2015;16(10):1358\u201377.","journal-title":"EMBO Rep"},{"issue":"1","key":"2039_CR41","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1038\/srep02535","volume":"3","author":"E Leucci","year":"2013","unstructured":"Leucci E, Patella F, Waage J, Holmstr\u00f8m K, Lindow M, Porse B, et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep. 2013;3(1):2535.","journal-title":"Sci Rep"},{"issue":"8","key":"2039_CR42","first-page":"3478","volume":"23","author":"B Liu","year":"2019","unstructured":"Liu B, Qiang L, Wang GD, Duan Q, Liu J. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145\/ZEB2 axis. Eur Rev Med Pharmacol Sci. 2019;23(8):3478\u201386.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"2039_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1139\/bcb-2019-0434","volume":"98","author":"J Liu","year":"2020","unstructured":"Liu J, Xu L, Zhan X. LncRNA MALAT1 regulates diabetic cardiac fibroblasts through the Hippo\u2013YAP signaling pathway. Biochem Cell Biol. 2020;98(5):537\u201347.","journal-title":"Biochem Cell Biol"},{"issue":"5","key":"2039_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/dmrr.322","volume":"18","author":"D Hileeto","year":"2002","unstructured":"Hileeto D, Cukiernik M, Mukherjee S, Evans T, Barbin Y, Downey D, et al. Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium. Diabetes Metab Res Rev. 2002;18(5):386\u201394.","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"2039_CR45","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427\u201331.","journal-title":"Bioinformatics"},{"issue":"36","key":"2039_CR46","doi-asserted-by":"publisher","first-page":"13556","DOI":"10.1073\/pnas.0803055105","volume":"105","author":"A Lujambio","year":"2008","unstructured":"Lujambio A, Calin GA, Villanueva A, Ropero S, S\u00e1nchez-C\u00e9spedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci. 2008;105(36):13556\u201361.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2039_CR47","doi-asserted-by":"publisher","first-page":"43798","DOI":"10.1038\/srep43798","volume":"7","author":"D Liang","year":"2017","unstructured":"Liang D, Wang Z, Yan Z, Hou S, Xu W, Wang L, et al. Nicotine facilitates VSMC dysfunction through a miR-200b\/RhoGDIA\/cytoskeleton module. Sci Rep. 2017;7(1):43798.","journal-title":"Sci Rep"},{"issue":"1","key":"2039_CR48","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1038\/s41598-018-24907-w","volume":"8","author":"S Biswas","year":"2018","unstructured":"Biswas S, Thomas AA, Chen S, Aref-Eshghi E, Feng B, Gonder J, et al. MALAT1: an epigenetic regulator of inflammation in diabetic retinopathy. Sci Rep. 2018;8(1):6526.","journal-title":"Sci Rep"},{"issue":"4","key":"2039_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvx253","volume":"114","author":"C Souilhol","year":"2018","unstructured":"Souilhol C, Harmsen MC, Evans PC, Krenning G. Endothelial\u2013mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018;114(4):565\u201377.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"2039_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.734550","volume":"17","author":"Q Huang","year":"2021","unstructured":"Huang Q, Gan Y, Yu Z, Wu H, Zhong Z. Endothelial to mesenchymal transition: an insight in atherosclerosis. Front Cardiovasc Med. 2021;17(8): 734550.","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"2039_CR51","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1172\/JCI82719","volume":"125","author":"PY Chen","year":"2015","unstructured":"Chen PY, Qin L, Baeyens N, Li G, Afolabi T, Budatha M, et al. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest. 2015;125(12):4514\u201328.","journal-title":"J Clin Invest"},{"issue":"1","key":"2039_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2015.07.008","volume":"242","author":"J Hjortnaes","year":"2015","unstructured":"Hjortnaes J, Shapero K, Goettsch C, Hutcheson JD, Keegan J, Kluin J, et al. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis. 2015;242(1):251\u201360.","journal-title":"Atherosclerosis"},{"issue":"3","key":"2039_CR53","first-page":"183","volume":"36","author":"X Ma","year":"2020","unstructured":"Ma X, Zhao D, Yuan P, Li J, Yun Y, Cui Y, et al. Endothelial-to-mesenchymal transition in calcific aortic valve disease. Acta Cardiol Sin. 2020;36(3):183\u201394.","journal-title":"Acta Cardiol Sin"},{"issue":"3","key":"2039_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jcp.22322","volume":"225","author":"G Krenning","year":"2010","unstructured":"Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225(3):631\u20137.","journal-title":"J Cell Physiol"},{"issue":"16","key":"2039_CR55","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.3390\/ijms22168629","volume":"22","author":"NP Jordan","year":"2021","unstructured":"Jordan NP, Tingle SJ, Shuttleworth VG, Cooke K, Redgrave RE, Singh E, et al. MiR-126-3p is dynamically regulated in endothelial-to-mesenchymal transition during fibrosis. Int J Mol Sci. 2021;22(16):8629.","journal-title":"Int J Mol Sci"},{"issue":"275","key":"2039_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2018.05.046","volume":"1","author":"H Tang","year":"2018","unstructured":"Tang H, Zhu M, Zhao G, Fu W, Shi Z, Ding Y, et al. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability. Atherosclerosis. 2018;1(275):58\u201367.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2039_CR57","doi-asserted-by":"publisher","first-page":"20304","DOI":"10.1038\/srep20304","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, et al. ROCK1 induces endothelial-to-mesenchymal transition in glomeruli to aggravate albuminuria in diabetic nephropathy. Sci Rep. 2016;6(1):20304.","journal-title":"Sci Rep"},{"issue":"1","key":"2039_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13098-022-00791-3","volume":"14","author":"Z Geng","year":"2022","unstructured":"Geng Z, Dong B, Lv W, Wang Z, Wang X, Huang Y, et al. LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588\/ROCK1 axis. Diabetol Metab Syndr. 2022;14(1):21.","journal-title":"Diabetol Metab Syndr"},{"issue":"21","key":"2039_CR59","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1111\/jcmm.16890","volume":"25","author":"T Ni","year":"2021","unstructured":"Ni T, Huang X, Pan S, Lu Z. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J Cell Mol Med. 2021;25(21):9995\u201310007.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2039_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","volume":"471","author":"P Jeyabal","year":"2016","unstructured":"Jeyabal P, Thandavarayan RA, Joladarashi D, Babu SS, Krishnamurthy S, Bhimaraj A, et al. MicroRNA-9 inhibits hyperglycemia induced cardiac pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun. 2016;471(4):423\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"203","key":"2039_CR61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2015.10.136","volume":"15","author":"M Zhang","year":"2016","unstructured":"Zhang M, Gu H, Xu W, Zhou X. Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. Int J Cardiol. 2016;15(203):214\u20136.","journal-title":"Int J Cardiol"},{"issue":"12","key":"2039_CR62","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.ymthe.2017.09.009","volume":"25","author":"K Singh","year":"2017","unstructured":"Singh K, Pal D, Sinha M, Ghatak S, Gnyawali SC, Khanna S, et al. Epigenetic modification of microRNA-200b contributes to diabetic vasculopathy. Mol Ther. 2017;25(12):2689\u2013704.","journal-title":"Mol Ther"},{"issue":"4","key":"2039_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123987","volume":"10","author":"MA Ruiz","year":"2015","unstructured":"Ruiz MA, Feng B, Chakrabarti S. Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy. PLoS ONE. 2015;10(4): e0123987.","journal-title":"PLoS ONE"},{"key":"2039_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00355","author":"WY Lo","year":"2018","unstructured":"Lo WY, Yang WK, Peng CT, Pai WY, Wang HJ. MicroRNA-200a\/200b modulate high glucose-induced endothelial inflammation by targeting O-linked N-acetylglucosamine transferase expression. Front Physiol. 2018. https:\/\/doi.org\/10.3389\/fphys.2018.00355.","journal-title":"Front Physiol"},{"issue":"6","key":"2039_CR65","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1101\/gr.133728.111","volume":"22","author":"AB Brinkman","year":"2012","unstructured":"Brinkman AB, Gu H, Bartels SJJ, Zhang Y, Matarese F, Simmer F, et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 2012;22(6):1128\u201338.","journal-title":"Genome Res"},{"issue":"1","key":"2039_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053880","volume":"8","author":"JA Hagarman","year":"2013","unstructured":"Hagarman JA, Motley MP, Kristjansdottir K, Soloway PD. Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells. PLoS ONE. 2013;8(1): e53880.","journal-title":"PLoS ONE"},{"issue":"1","key":"2039_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2013.08.056","volume":"155","author":"F Neri","year":"2013","unstructured":"Neri F, Krepelova A, Incarnato D, Maldotti M, Parlato C, Galvagni F, et al. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell. 2013;155(1):121\u201334.","journal-title":"Cell"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02039-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02039-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02039-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:02:08Z","timestamp":1699038128000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02039-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02039-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Western Health Sciences Research Ethics Board and Lawson Health Research Institute at the University of Western Ontario (London, ON, CAN), and conducted in accordance with the principles of the Declaration of Helsinki. Cardiac tissues were collected from autopsy patients after informed consent was obtained from relatives for the scientific use of tissue samples in the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}